NovoCure (NVCR) News Today $18.08 -0.12 (-0.65%) As of 11:21 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Soleus Capital Management L.P. Takes Position in NovoCure Limited (NASDAQ:NVCR)Soleus Capital Management L.P. bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,739,704 shares of the medical equipment provider'sMay 21 at 8:13 AM | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Acquired by Deutsche Bank AGDeutsche Bank AG grew its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 20.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 194,327 shares of the medical equipment provider's stock afterMay 21 at 3:52 AM | marketbeat.comTeza Capital Management LLC Purchases 85,312 Shares of NovoCure Limited (NASDAQ:NVCR)Teza Capital Management LLC lifted its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 573.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 100,200 shares of the medical equipment proviMay 20 at 7:40 AM | marketbeat.comSilvercrest Asset Management Group LLC Decreases Stock Position in NovoCure Limited (NASDAQ:NVCR)Silvercrest Asset Management Group LLC cut its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 29.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 348,307 shares of the medical equipment pMay 20 at 5:46 AM | marketbeat.comQuantinno Capital Management LP Acquires 43,108 Shares of NovoCure Limited (NASDAQ:NVCR)Quantinno Capital Management LP increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 17.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 294,639 shares of the medical equipment provider's stock afteMay 18 at 5:49 AM | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Graham Capital Management L.P.Graham Capital Management L.P. reduced its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 59.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,709 shares of the medical equipmMay 17, 2025 | marketbeat.comLMR Partners LLP Buys Shares of 32,914 NovoCure Limited (NASDAQ:NVCR)LMR Partners LLP bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 32,914 shares of the medical equipment provider's stock, valued at approximMay 16, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Receives $32.83 Average Price Target from AnalystsMay 13, 2025 | americanbankingnews.comNorthern Trust Corp Boosts Holdings in NovoCure Limited (NASDAQ:NVCR)Northern Trust Corp grew its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 39.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,284,350 shares of the medical equipment provider's stock afterMay 12, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Given Average Rating of "Moderate Buy" by AnalystsNovoCure Limited (NASDAQ:NVCR - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buMay 12, 2025 | marketbeat.comFrontier Capital Management Co. LLC Sells 145,096 Shares of NovoCure Limited (NASDAQ:NVCR)Frontier Capital Management Co. LLC decreased its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 726,324 shares of the medical equipment pMay 11, 2025 | marketbeat.comAlgert Global LLC Buys Shares of 69,261 NovoCure Limited (NASDAQ:NVCR)Algert Global LLC purchased a new position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 69,261 shares of the medical equipment provider's stoMay 11, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Reduces Stock Position in NovoCure Limited (NASDAQ:NVCR)The Manufacturers Life Insurance Company trimmed its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 24.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 152,602 shares of the medical equipment provider'sMay 11, 2025 | marketbeat.comCubist Systematic Strategies LLC Increases Position in NovoCure Limited (NASDAQ:NVCR)Cubist Systematic Strategies LLC lifted its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 223.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 335,218 shares of the medical equipment provider's stock after buying an adMay 10, 2025 | marketbeat.comBalyasny Asset Management L.P. Grows Stock Holdings in NovoCure Limited (NASDAQ:NVCR)Balyasny Asset Management L.P. boosted its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 27.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,068,863 shares of the medical eqMay 9, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Takes Position in NovoCure Limited (NASDAQ:NVCR)Schonfeld Strategic Advisors LLC purchased a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 105,280 shares of the medical equipment provider's stock, valued at approximately $May 6, 2025 | marketbeat.comPDT Partners LLC Trims Holdings in NovoCure Limited (NASDAQ:NVCR)PDT Partners LLC reduced its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 28.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 80,232 shares of the medical equipment provider's stock after selling 31,8May 2, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD cut its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,683,818 shares of the medical equipment provider's stock after selling 638,37May 2, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Makes New Investment in NovoCure Limited (NASDAQ:NVCR)Emerald Mutual Fund Advisers Trust bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 325,255 shares of the medical equipment provider's stock, valuedMay 1, 2025 | marketbeat.com200,000 Shares in NovoCure Limited (NASDAQ:NVCR) Acquired by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. acquired a new position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 200,000 shares of the medical equipment provider's stock, valued at apMay 1, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Trims Holdings in NovoCure Limited (NASDAQ:NVCR)T. Rowe Price Investment Management Inc. lowered its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 39.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,690,441 shares of the medical equipment provider's stock after selling 1,115,6April 28, 2025 | marketbeat.comInvesco Ltd. Acquires 79,698 Shares of NovoCure Limited (NASDAQ:NVCR)Invesco Ltd. grew its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 72.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 189,474 shares of the medical equipment provider's stock after purchasing an additional 79,698 shares durinApril 28, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Cut to "Sell" at StockNews.comStockNews.com lowered NovoCure from a "hold" rating to a "sell" rating in a research note on Friday.April 27, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call TranscriptApril 25, 2025 | msn.comWhy NovoCure Stock Skyrocketed This WeekApril 25, 2025 | fool.comNovocure outlines expansion plans for lung cancer treatment and regulatory milestones in 2025April 25, 2025 | msn.comMarshall Wace LLP Has $8.07 Million Holdings in NovoCure Limited (NASDAQ:NVCR)Marshall Wace LLP lessened its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 65.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 270,952 shares of the medical equiApril 25, 2025 | marketbeat.comNovocure’s NSCLC launch momentum ‘positive,’ says H.C. WainwrightApril 24, 2025 | markets.businessinsider.comWhy NovoCure Stock Leaped 4% Higher TodayApril 24, 2025 | fool.comNovocure reports Q1 EPS (31c), consensus (46c)April 24, 2025 | markets.businessinsider.comNovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025April 24, 2025 | benzinga.comNovoCure Surpasses Q1 ExpectationsApril 24, 2025 | fool.comNovoCure Limited 2025 Q1 - Results - Earnings Call PresentationApril 24, 2025 | seekingalpha.comNovocure Reports First Quarter 2025 Financial ResultsApril 24, 2025 | businesswire.comNovocure to present Phase 3 PANOVA-3 trial results at ASCO 2025April 24, 2025 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on NovoCure (NVCR)April 24, 2025 | markets.businessinsider.com5NVCR : NovoCure's Earnings: A PreviewApril 23, 2025 | benzinga.comNovocure announces CE Mark for Optune LuaApril 23, 2025 | markets.businessinsider.comNovocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual MeetingApril 23, 2025 | businesswire.comCapital World Investors Raises Holdings in NovoCure Limited (NASDAQ:NVCR)Capital World Investors grew its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 11.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,815,529 shares of the medical equipment provider's stApril 23, 2025 | marketbeat.comLegal & General Group Plc Sells 26,654 Shares of NovoCure Limited (NASDAQ:NVCR)Legal & General Group Plc cut its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 14.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 157,758 shares of the medical equiApril 23, 2025 | marketbeat.comLPL Financial LLC Acquires Shares of 27,861 NovoCure Limited (NASDAQ:NVCR)LPL Financial LLC bought a new position in NovoCure Limited (NASDAQ:NVCR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 27,861 shares of the medical equipment provider's stock, valued at approximately $830,000. SeveralApril 23, 2025 | marketbeat.comNovocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung CancerApril 22, 2025 | finance.yahoo.comNovocure's Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung CancerApril 22, 2025 | businesswire.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Bridgewater Associates LPBridgewater Associates LP trimmed its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 71.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,119 shares of the medical equipment provider's sApril 22, 2025 | marketbeat.comCapital International Investors Grows Position in NovoCure Limited (NASDAQ:NVCR)Capital International Investors raised its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 12.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,873,902 shares of the medical equipment proviApril 21, 2025 | marketbeat.comWedbush Predicts NovoCure's Q1 Earnings (NASDAQ:NVCR)NovoCure Limited (NASDAQ:NVCR - Free Report) - Equities research analysts at Wedbush reduced their Q1 2025 earnings estimates for shares of NovoCure in a research report issued on Wednesday, April 16th. Wedbush analyst D. Nierengarten now forecasts that the medical equipment provider will earn ($April 20, 2025 | marketbeat.comJump Financial LLC Increases Stock Holdings in NovoCure Limited (NASDAQ:NVCR)Jump Financial LLC lifted its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 28.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 176,252 shares of the medical equipment provider's stock after puApril 19, 2025 | marketbeat.comNovoCure (NVCR) Expected to Announce Earnings on ThursdayNovoCure (NASDAQ:NVCR) will be releasing earnings before the market opens on Thursday, April 24, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=679467)April 19, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Upgraded to "Hold" at StockNews.comStockNews.com upgraded shares of NovoCure from a "sell" rating to a "hold" rating in a research report on Thursday.April 19, 2025 | marketbeat.com Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCR Media Mentions By Week NVCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCR News Sentiment▼1.240.65▲Average Medical News Sentiment NVCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCR Articles This Week▼75▲NVCR Articles Average Week Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Stevanato Group News Glaukos News Inari Medical News iRhythm Technologies News Inspire Medical Systems News Bausch + Lomb News TransMedics Group News Soleno Therapeutics News PROCEPT BioRobotics News Envista News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVCR Stock Free NVCR Stock Alerts